table of content
1 Introduction to Research & Analysis Reports
1.1 Adalimumab Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adalimumab Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adalimumab Injection Overall Market Size
2.1 Global Adalimumab Injection Market Size: 2023 VS 2030
2.2 Global Adalimumab Injection Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Adalimumab Injection Sales: 2019-2030
3 Company Landscape
3.1 Top Adalimumab Injection Players in Global Market
3.2 Top Global Adalimumab Injection Companies Ranked by Revenue
3.3 Global Adalimumab Injection Revenue by Companies
3.4 Global Adalimumab Injection Sales by Companies
3.5 Global Adalimumab Injection Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Adalimumab Injection Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Adalimumab Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adalimumab Injection Players in Global Market
3.8.1 List of Global Tier 1 Adalimumab Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Adalimumab Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Adalimumab Injection Market Size Markets, 2023 & 2030
4.1.2 40mg/0.8ml
4.1.3 20mg/0.4ml
4.2 By Type - Global Adalimumab Injection Revenue & Forecasts
4.2.1 By Type - Global Adalimumab Injection Revenue, 2019-2024
4.2.2 By Type - Global Adalimumab Injection Revenue, 2025-2030
4.2.3 By Type - Global Adalimumab Injection Revenue Market Share, 2019-2030
4.3 By Type - Global Adalimumab Injection Sales & Forecasts
4.3.1 By Type - Global Adalimumab Injection Sales, 2019-2024
4.3.2 By Type - Global Adalimumab Injection Sales, 2025-2030
4.3.3 By Type - Global Adalimumab Injection Sales Market Share, 2019-2030
4.4 By Type - Global Adalimumab Injection Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adalimumab Injection Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Adalimumab Injection Revenue & Forecasts
5.2.1 By Application - Global Adalimumab Injection Revenue, 2019-2024
5.2.2 By Application - Global Adalimumab Injection Revenue, 2025-2030
5.2.3 By Application - Global Adalimumab Injection Revenue Market Share, 2019-2030
5.3 By Application - Global Adalimumab Injection Sales & Forecasts
5.3.1 By Application - Global Adalimumab Injection Sales, 2019-2024
5.3.2 By Application - Global Adalimumab Injection Sales, 2025-2030
5.3.3 By Application - Global Adalimumab Injection Sales Market Share, 2019-2030
5.4 By Application - Global Adalimumab Injection Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Adalimumab Injection Market Size, 2023 & 2030
6.2 By Region - Global Adalimumab Injection Revenue & Forecasts
6.2.1 By Region - Global Adalimumab Injection Revenue, 2019-2024
6.2.2 By Region - Global Adalimumab Injection Revenue, 2025-2030
6.2.3 By Region - Global Adalimumab Injection Revenue Market Share, 2019-2030
6.3 By Region - Global Adalimumab Injection Sales & Forecasts
6.3.1 By Region - Global Adalimumab Injection Sales, 2019-2024
6.3.2 By Region - Global Adalimumab Injection Sales, 2025-2030
6.3.3 By Region - Global Adalimumab Injection Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Adalimumab Injection Revenue, 2019-2030
6.4.2 By Country - North America Adalimumab Injection Sales, 2019-2030
6.4.3 US Adalimumab Injection Market Size, 2019-2030
6.4.4 Canada Adalimumab Injection Market Size, 2019-2030
6.4.5 Mexico Adalimumab Injection Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Adalimumab Injection Revenue, 2019-2030
6.5.2 By Country - Europe Adalimumab Injection Sales, 2019-2030
6.5.3 Germany Adalimumab Injection Market Size, 2019-2030
6.5.4 France Adalimumab Injection Market Size, 2019-2030
6.5.5 U.K. Adalimumab Injection Market Size, 2019-2030
6.5.6 Italy Adalimumab Injection Market Size, 2019-2030
6.5.7 Russia Adalimumab Injection Market Size, 2019-2030
6.5.8 Nordic Countries Adalimumab Injection Market Size, 2019-2030
6.5.9 Benelux Adalimumab Injection Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Adalimumab Injection Revenue, 2019-2030
6.6.2 By Region - Asia Adalimumab Injection Sales, 2019-2030
6.6.3 China Adalimumab Injection Market Size, 2019-2030
6.6.4 Japan Adalimumab Injection Market Size, 2019-2030
6.6.5 South Korea Adalimumab Injection Market Size, 2019-2030
6.6.6 Southeast Asia Adalimumab Injection Market Size, 2019-2030
6.6.7 India Adalimumab Injection Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Adalimumab Injection Revenue, 2019-2030
6.7.2 By Country - South America Adalimumab Injection Sales, 2019-2030
6.7.3 Brazil Adalimumab Injection Market Size, 2019-2030
6.7.4 Argentina Adalimumab Injection Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Adalimumab Injection Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Adalimumab Injection Sales, 2019-2030
6.8.3 Turkey Adalimumab Injection Market Size, 2019-2030
6.8.4 Israel Adalimumab Injection Market Size, 2019-2030
6.8.5 Saudi Arabia Adalimumab Injection Market Size, 2019-2030
6.8.6 UAE Adalimumab Injection Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Adalimumab Injection Major Product Offerings
7.1.4 AbbVie Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Adalimumab Injection Major Product Offerings
7.2.4 Amgen Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Adalimumab Injection Major Product Offerings
7.3.4 Sandoz Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.3.5 Sandoz Key News & Latest Developments
7.4 Fresenius Kabi
7.4.1 Fresenius Kabi Company Summary
7.4.2 Fresenius Kabi Business Overview
7.4.3 Fresenius Kabi Adalimumab Injection Major Product Offerings
7.4.4 Fresenius Kabi Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.4.5 Fresenius Kabi Key News & Latest Developments
7.5 Biogen
7.5.1 Biogen Company Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Adalimumab Injection Major Product Offerings
7.5.4 Biogen Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.5.5 Biogen Key News & Latest Developments
7.6 Celltrion
7.6.1 Celltrion Company Summary
7.6.2 Celltrion Business Overview
7.6.3 Celltrion Adalimumab Injection Major Product Offerings
7.6.4 Celltrion Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.6.5 Celltrion Key News & Latest Developments
7.7 Cadila Pharmaceuticals
7.7.1 Cadila Pharmaceuticals Company Summary
7.7.2 Cadila Pharmaceuticals Business Overview
7.7.3 Cadila Pharmaceuticals Adalimumab Injection Major Product Offerings
7.7.4 Cadila Pharmaceuticals Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.7.5 Cadila Pharmaceuticals Key News & Latest Developments
7.8 Bio-Thera Solutions, Ltd.
7.8.1 Bio-Thera Solutions, Ltd. Company Summary
7.8.2 Bio-Thera Solutions, Ltd. Business Overview
7.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Major Product Offerings
7.8.4 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.8.5 Bio-Thera Solutions, Ltd. Key News & Latest Developments
7.9 Hisun Biopharmaceutical
7.9.1 Hisun Biopharmaceutical Company Summary
7.9.2 Hisun Biopharmaceutical Business Overview
7.9.3 Hisun Biopharmaceutical Adalimumab Injection Major Product Offerings
7.9.4 Hisun Biopharmaceutical Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.9.5 Hisun Biopharmaceutical Key News & Latest Developments
7.10 Innovent Biologics
7.10.1 Innovent Biologics Company Summary
7.10.2 Innovent Biologics Business Overview
7.10.3 Innovent Biologics Adalimumab Injection Major Product Offerings
7.10.4 Innovent Biologics Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.10.5 Innovent Biologics Key News & Latest Developments
7.11 Mylan
7.11.1 Mylan Company Summary
7.11.2 Mylan Adalimumab Injection Business Overview
7.11.3 Mylan Adalimumab Injection Major Product Offerings
7.11.4 Mylan Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.11.5 Mylan Key News & Latest Developments
7.12 Zydus Group
7.12.1 Zydus Group Company Summary
7.12.2 Zydus Group Adalimumab Injection Business Overview
7.12.3 Zydus Group Adalimumab Injection Major Product Offerings
7.12.4 Zydus Group Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.12.5 Zydus Group Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Adalimumab Injection Business Overview
7.13.3 Boehringer Ingelheim Adalimumab Injection Major Product Offerings
7.13.4 Boehringer Ingelheim Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
7.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Summary
7.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
7.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Major Product Offerings
7.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Key News & Latest Developments
7.15 Shanghai Henlius Biotech
7.15.1 Shanghai Henlius Biotech Company Summary
7.15.2 Shanghai Henlius Biotech Business Overview
7.15.3 Shanghai Henlius Biotech Adalimumab Injection Major Product Offerings
7.15.4 Shanghai Henlius Biotech Adalimumab Injection Sales and Revenue in Global (2019-2024)
7.15.5 Shanghai Henlius Biotech Key News & Latest Developments
8 Global Adalimumab Injection Production Capacity, Analysis
8.1 Global Adalimumab Injection Production Capacity, 2019-2030
8.2 Adalimumab Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Adalimumab Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adalimumab Injection Supply Chain Analysis
10.1 Adalimumab Injection Industry Value Chain
10.2 Adalimumab Injection Upstream Market
10.3 Adalimumab Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adalimumab Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
